RankingsPricing
  1. JP-listed companies
  2. PhoenixBio Co.,Ltd.
  3. Financials
  4. Gross margin (%)

PhoenixBio Co.,Ltd.JP:6190

Market cap
¥1.9B
P/E ratio
17.7x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndGross margin (%) YoY (%)
Mar 31, 202572.5+4.08%
Mar 31, 202469.7-4.92%
Mar 31, 202373.3+33.39%
Mar 31, 202254.9-5.33%
Mar 31, 202158-12.17%
Mar 31, 202066.1-4.67%
Mar 31, 201969.3+23.66%
Mar 31, 201856-18.01%
Mar 31, 201768.4+0.40%
Mar 31, 201668.1-2.21%
Mar 31, 201569.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)